BIOLOGICAL RHYTHMS IN THE INFLAMMATORY RESPONSE AND IN THE EFFECTS OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS

被引:45
作者
LABRECQUE, G
BUREAU, JP
REINBERG, AE
机构
[1] CHU LAVAL,DEPT PHARM,ST FOY,PQ G1V 4G2,CANADA
[2] FAC MED NIMES,CYTOL & IMMUNOGENET LAB,F-30900 NIMES,FRANCE
[3] FDN ADOLPHE DE ROTHSCHILD,CHRONOPHARMACOL HUMAINE LAB,F-75940 PARIS,FRANCE
关键词
CIRCADIAN RHYTHMS; CHRONOTOLERANCE; DRUG EFFECTIVENESS; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; OSTEOARTHRITIS; RHEUMATOID ARTHRITIS;
D O I
10.1016/0163-7258(94)00082-E
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
It is well known that some signs and symptoms of rheumatoid arthritis (RA) vary within a day and between days, and the morning stiffness observed in RA patients has become one of the diagnostic criteria of the disease. Research carried out in the last 10 years confirmed these clinical observations, and circadian, circaseptan or circannual variations were detected in experimental inflammation and in patients with arthritic diseases. The human data showed also that large interindividual differences can be found in the symptoms of RA. The chronopharmacological studies carried out with the non-steroidal anti-inflammatory drugs (NSAID) revealed circadian and circannual variations in the effectiveness, toxicity acid pharmacokinetics of NSAID. A review of the available data suggests that peak and trough values found in different arthritic diseases do not occur at the same hour of the day and that the side effects produced by NSAID an more important after the morning than the evening administration. This information should be used by clinicians to determine when to administer drugs to arthritic patients, to optimize the effectiveness of NSAID and/or to reduce the side effects of these drugs. These new data could also be useful to physicians who would like to individualize NSAID use in patients with different arthritic diseases.
引用
收藏
页码:285 / 300
页数:16
相关论文
共 59 条
[1]  
ALVIN M, 1988, ANN REV CHROMOPHARMA, V5, P17
[2]  
BELANGER P, 1982, TRIBUNE MED S, V1, P14
[3]  
BELLAMY N, 1990, J RHEUMATOL, V17, P364
[4]  
BOISSIER C, 1990, ANN R CHRON, V7, P289
[5]  
BOUCHANCOURT P, 1982, TRIBUNE MED S, V1, P32
[6]  
BROTHERS GB, 1983, J RHEUMATOL, V10, P471
[7]  
BRUGUEROLLE B, 1983, RHUMATOLOGIE PARIS, V13, P263
[8]  
BRUGUEROLLE B, 1986, ANN REV CHRONOPHARMA, V3, P425
[9]  
BUREAU J-P, 1986, Chronobiology International, V3, P23, DOI 10.3109/07420528609083156
[10]  
BUREAU JP, 1991, INT J TISSUE REACT, V13, P203